Double‐blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 692-701

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prospective randomized double‐blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO‐AB 31/05)

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 429-436

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 2973-2980

John Wiley & Sons Inc

Access to resources Recommend Favorite

Larotaxel with Cisplatin in the First-Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer: A Randomized, Active-Controlled, Phase III Trial (CILAB)

By  

Oncology, Vol. 85, Iss. 4, 2013-09 ,pp. : 208-215

Karger

Access to resources Recommend Favorite

Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy‐induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 10, 2015-10 ,pp. : 911-914

John Wiley & Sons Inc

Access to resources Recommend Favorite